Growth Metrics

Cytosorbents (CTSO) Net Income (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 40.04%
Dec 31, 2025 -105.24%
Sep 30, 2025 25.08%
Jun 30, 2025 -186.20%
Mar 31, 2025 80.46%
Dec 31, 2024 -173.37%
Sep 30, 2024 33.19%
Jun 30, 2024 31.95%
Mar 31, 2024 -139.69%
Dec 31, 2023 266.85%
Sep 30, 2023 -49.41%
Jun 30, 2023 16.01%
Mar 31, 2023 -856.22%
Dec 31, 2022 93.72%
Sep 30, 2022 -12.15%
Jun 30, 2022 -21.33%
Mar 31, 2022 3.66%
Dec 31, 2021 -45.28%
Sep 30, 2021 -36.96%
Jun 30, 2021 -12.23%
Mar 31, 2021 -514.97%
Dec 31, 2020 19.29%
Sep 30, 2020 70.71%
Jun 30, 2020 16.97%
Mar 31, 2020 12.57%
Dec 31, 2019 42.64%
Sep 30, 2019 -94.09%
Jun 30, 2019 27.36%
Mar 31, 2019 9.61%
Dec 31, 2018 -79.82%
Sep 30, 2018 48.38%
Jun 30, 2018 -95.21%
Mar 31, 2018 5.24%
Dec 31, 2017 -53.19%
Sep 30, 2017 -18.43%
Jun 30, 2017 -13.76%
Mar 31, 2017 68.92%
Dec 31, 2016 -124.21%
Sep 30, 2016 27.19%
Jun 30, 2016 -63.66%
Mar 31, 2016 45.14%
Dec 31, 2015 -17.54%
Sep 30, 2015 -298.52%
Jun 30, 2015 130.41%
Mar 31, 2015 12.33%
Dec 31, 2014 -259.08%
Sep 30, 2014 19.17%
Jun 30, 2014 -90.10%
Mar 31, 2014 13.51%
Dec 31, 2013 -16.85%
Sep 30, 2013 31.82%
Jun 30, 2013 13.13%
Mar 31, 2013 -202.99%
Dec 31, 2012 17.54%
Sep 30, 2012 37.75%
Jun 30, 2012 26.59%
Mar 31, 2012 -19.19%
Dec 31, 2011 30.77%
Sep 30, 2011 -28.91%
Jun 30, 2011 -10.42%
Mar 31, 2011 -155.65%
Dec 31, 2010 39.74%
Sep 30, 2010 -16.58%